FDA Inspection 920094 — Piramal Pharma Limited

Piramal Pharma Limited — FEI 3008763768

The FDA completed an inspection of Piramal Pharma Limited on Feb 13, 2015 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 13, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Navi Mumbai (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.